Tender timing volatility in animal healthcare
Animal healthcare revenue fell 30% YoY due to delayed government tenders; recovery depends on timely rollout.
high · management_commentaryHester Biosciences Limited — Q4 FY26
Hester Biosciences reported a strong Q4 FY26 with standalone revenue growing 22% YoY and PAT surging 174% YoY, driven by a 41% YoY jump in poultry healthcare revenue.
bullish
medium
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Rising raw material costs
Global geopolitical developments and supply chain disruptions are increasing raw material costs, pressuring margins.
medium · management_commentaryHigh receivables and working capital
Receivables of ₹92 crore on ~₹300 crore revenue are elevated; Q4 sales spike contributed but management is working to reduce days.
medium · analyst_questionRegulatory changes requiring additional capex
Evolving regulatory requirements may necessitate further capital allocation, though management did not quantify.
low · analyst_question